AtriCure Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.47 |
Market Cap |
$1.21 B |
Shares Outstanding |
38.62 M |
Public Float |
36.75 M |
Address |
7555 Innovation Way Mason Ohio 45069 United States |
Employees | - |
Website | http://www.atricure.com |
Updated | 07/08/2019 |
AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures. |